Literature DB >> 24789580

Excretion of tectorigenin in rat urine orally administrated at different dosages by ultra-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.

Ziming Shi1, Guozhe Zhang, Lizhu Zhao, Shen Wang, Yoshihiro Kano, Dan Yuan.   

Abstract

Tectorigenin (Te) is a main active component in the flowers of Pueraria thomsonii Benth. and the rhizomes of Belamcanda chinensis (L.) DC. Previously, we have reported the pharmacokinetic properties of Te in rat plasma. The purpose of this study was to investigate the urinary excretion of Te after oral administration to rats at different dose levels. Using UHPLC/Q-TOFMS, totally 26 metabolites were detected in rat urine after oral administration of Te at dose of 65 and 130 mg/kg. Among them, nine metabolites, Te, tectorigenin-7-O-glucuronide-4'-sulfate (Te-7G-4'S), tectorigenin-7-O-glucuronide (Te-7G), tectorigenin-7-O-sulfate (Te-7S), tectorigenin-4'-O-glucuronide (Te-4'S), isotectorigenin, genistein, irisolidone-7-O-glucuronide (Ir-7G), and irisolidone, were identified by comparing the retention time, UV and MS spectra with those of authentic standards. A UHPLC/Q-TOFMS method for simultaneous quantification and semi-quantification of all the metabolites in urine was developed. The cumulative urinary excretions of Te and the major metabolite Te-7G were 1.99 and 5.80 μmol at 65 mg/kg, 3.05 and 6.48 μmol at 130 mg/kg, accounted for 4.17 % and 15.8, 2.81 and 9.49 % of administrated Te, respectively. The excretion rates of Te-7G, Te-7G-4'S, Ir-7G, and Te reached a maximum between 12 and 24 h after oral dosing at 65 and 130 mg/kg. The cumulative urine excretion rates of Te were 23.1 and 20.1 % within 72 h at 65 and 130 mg/kg, respectively. These results suggested that the glucuronidation was the primary metabolic pathway especially at low dose level.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24789580     DOI: 10.1007/s13318-014-0202-0

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  23 in total

1.  Simultaneous determination of tectorigenin, irigenin and irisflorentin in rat plasma and urine by UHPLC-MS/MS: application to pharmacokinetics.

Authors:  Wei-dong Zhang; Wan-jun Yang; Xiao-juan Wang; Yi Gu; Rong Wang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-10-25       Impact factor: 3.205

2.  Pharmacokinetics of conjugated metabolites in rat plasma after oral administration of tectoridin.

Authors:  Jialin Qu; Jie Gao; Jiahong Sun; Lin Zhang; Toshiaki Makino; Dan Yuan
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-06-21       Impact factor: 3.205

3.  Quality evaluation of Rhizoma Belamcandae (Belamcanda chinensis (L.) DC.) by using high-performance liquid chromatography coupled with diode array detector and mass spectrometry.

Authors:  Jun Li; Winnie Z M Li; Wen Huang; Anna W H Cheung; Cathy W C Bi; Ran Duan; Ava J Y Guo; Tina T X Dong; Karl W K Tsim
Journal:  J Chromatogr A       Date:  2008-06-03       Impact factor: 4.759

4.  Hypoglycemic and hypolipidemic effects of tectorigenin and kaikasaponin III in the streptozotocin-lnduced diabetic rat and their antioxidant activity in vitro.

Authors:  K T Lee; I C Sohn; D H Kim; J W Choi; S H Kwon; H J Park
Journal:  Arch Pharm Res       Date:  2000-10       Impact factor: 4.946

5.  Pro-apoptotic effects of tectorigenin on human hepatocellular carcinoma HepG2 cells.

Authors:  Chun-Ping Jiang; Hui Ding; Da-Hua Shi; Yu-Rong Wang; Er-Guang Li; Jun-Hua Wu
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

6.  Hepatoprotective effect of tectoridin and tectorigenin on tert-butyl hyperoxide-induced liver injury.

Authors:  Hae-Ung Lee; Eun-Ah Bae; Dong-Hyun Kim
Journal:  J Pharmacol Sci       Date:  2005-04-09       Impact factor: 3.337

7.  Passive cutaneous anaphylaxis-inhibitory action of tectorigenin, a metabolite of tectoridin by intestinal microflora.

Authors:  Eun-Kyung Park; Yong-Wook Shin; Hae-Ung Lee; Chang Soo Lee; Dong-Hyun Kim
Journal:  Biol Pharm Bull       Date:  2004-07       Impact factor: 2.233

8.  Identification of metabolites of tectoridin in-vivo and in-vitro by liquid chromatography-tandem mass spectrometry.

Authors:  Yong Chen; Wei Song; Zhi H Peng; Bao Y Ge; Feng M Han
Journal:  J Pharm Pharmacol       Date:  2008-06       Impact factor: 3.765

9.  Toxicity, analgesic and anti-inflammatory activities of tectorigenin.

Authors:  Le Minh Ha; Do Thi Nguyet Que; Do Thi Thanh Huyen; Pham Quoc Long; Nguyen Tien Dat
Journal:  Immunopharmacol Immunotoxicol       Date:  2013-03-06       Impact factor: 2.730

10.  Isolation and identification of urinary metabolites of kakkalide in rats.

Authors:  Xue Bai; Yuanyuan Xie; Jia Liu; Jialin Qu; Yoshihiro Kano; Dan Yuan
Journal:  Drug Metab Dispos       Date:  2009-11-12       Impact factor: 3.922

View more
  2 in total

1.  UGT1A1 and UGT1A9 Are Responsible for Phase II Metabolism of Tectorigenin and Irigenin In Vitro.

Authors:  Ji Li; Zhangyao Xu; Jifeng Gu
Journal:  Molecules       Date:  2022-06-26       Impact factor: 4.927

2.  Systematic characterization of Puerariae Flos metabolites in vivo and assessment of its protective mechanisms against alcoholic liver injury in a rat model.

Authors:  Jialin Qu; Qiuyue Chen; Tianfu Wei; Ning Dou; Dong Shang; Dan Yuan
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.